New study aims to tailor ovarian cancer treatment for women over 70

NCT ID NCT06572735

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 50 women aged 70 and older with advanced ovarian cancer who are starting PARP inhibitors for the first time. Researchers will track how much of the planned dose patients actually receive, and look at factors like age, genetics, and overall health that might affect tolerance. The goal is to better understand how to manage side effects and keep patients on effective treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PARP inhibitors
What this could lead to
If successful, this could help doctors better manage side effects and dosing of PARP inhibitors in elderly patients, potentially improving treatment outcomes.
What could go wrong
This is a small observational study (50 patients) that does not test a new treatment. It only gathers data, so it will not directly change care immediately.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Georges François Leclerc

    RECRUITING

    Dijon, 21079, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Centre Hospitalier Privé Saint-Grégoire - Les Hôpitaux Privés Rennais

    RECRUITING

    Saint-Grégoire, 35760, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre Hospitalier Universitaire d'Amiens Picardie Site Sud

    RECRUITING

    Amiens, 80054, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Centre Hospitalier Valence

    RECRUITING

    Valence, 26953, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre de lutte contre le cancer Jean Perrin

    RECRUITING

    Clermont-Ferrand, 63011, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Clinique Mathilde

    RECRUITING

    Rouen, 76100, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Clinique de l'Europe

    RECRUITING

    Amiens, 80090, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Groupe Hospitalier Diaconesses Croix Saint Simon

    RECRUITING

    Paris, 75020, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Groupe Hospitalier Public Sud de l'Oise

    RECRUITING

    Creil, 60100, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hôpital Femme-Mère-Enfant

    RECRUITING

    Bron, 69500, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpital Privé Jean Mermoz

    RECRUITING

    Lyon, 69008, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institut de Cancérologie et d'Hématologie Universitaire de Saint Etienne

    RECRUITING

    Saint-Priest-en-Jarez, 42271, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Médipôle Hôpital Mutualiste

    RECRUITING

    Villeurbanne, 69100, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Service Hôpital de jour / Oncologie Médicale, Hôpital de la Croix Rousse

    RECRUITING

    Lyon, 69004, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Service Oncologie Médicale, Hôpital Lyon Sud

    RECRUITING

    Pierre-Bénite, 69495, France

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Service de Gériatrie, Hôpital Dr Frédéric Dugoujon

    RECRUITING

    Lyon, 69317, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.